Stephen M Perry, Chief Executive Officer and Founder of Kymanox, has more than two decades of experience in biopharmaceutical manufacturing with an emphasis on design engineering, scale-up, start-up and regulatory approval. Mr Perry has participated in the US FDA commercial approval of over two dozen unique drugs, devices, biologics and combination products. In 2004, he created Kymanox, a professional services firm specialising in the commercialisation of modern medicines. Prior to this, he held leadership roles at M+W Group (Stuttgart, Germany), Abbott Laboratories (IL, US), FujiFilm Diosynth Biotechnologies (TX, US) and Human Genome Sciences (MD, US). He holds a Bachelor’s degree in chemical engineering from the University of Notre Dame (IN, US) and studied at graduate level at Purdue University (IN, US).